Additional information
| Active substance | Temozolomide |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | CBC (Complete Blood Count) monitoring |
| Also known as | TMZ, Methazolastone |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No direct effect |
| Trade name | Temodar, Temodal, Temcad |
| Storage conditions | Store at controlled room temperature, 20-25В°C (68-77В°F) |
| Chemical name | 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide |
| Formula | C6H6N6O2 |
| Substance class | Alkylating agent |
| Main action | Antineoplastic |
| Half-life | 1.8 hours |
| Dosage (medical) | Typically 150-200 mg/mВІ per day for 5 days every 28 days cycle |
| Dosage (sports) | Not applicable |
| Effects | Antitumor effect, crosses the blood-brain barrier |
| Side effects | Nausea, vomiting, constipation, loss of appetite, alopecia, headache, fatigue, neutropenia, thrombocytopenia |
| Use in sports | None |
| Manufacturer | MSD |
Champix Starter Pack Pfizer
Spiriva HandiHaler 18mg Boehringer Ingelheim
FUCIDIN 500 mg Abdi Ibragim
Norvacs 10 mg Pfizer
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup
Champix 56 tabs Pfizer
Muscoflex 8 mg Bilim
Prograf 1mg Astellas Pharma
Seretide Disckus (Advair) 500 mcg Glaxosmithkline 

Reviews
There are no reviews yet.